Ruxolitinib and the Mitigation of Severe COVID-19: A Systematic Review and Meta-analysis.
Infect Chemother. 2021 Sep;53(3):436-448. doi: 10.3947/ic.2020.0126.
Infect Chemother. 2021.
PMID: 34623777
Free PMC article.